Role of somatostatin in the incidence of post – ERCP pancreatitis

Phase 4

• Conditions: Pancreatitis.; Acute pancreatitis, unspecified; K85.9

• Registration Number: IRCT20080921001264N11
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

All patients with biliary tract problems who refer to 5 Azar Hospital in gorgan to perform ERCP diagnostic-therapeutic method from the beginning of April 2017.

Exclusion Criteria

Previous history of sphincterotomy
history of chronic pancreatitis
acute pancreatitis when visiting
Allergy to somatostatin or NSAIDS

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pancreatitis. Timepoint: 2 and 18 hours. Method of measurement: serum amylase.